Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArmadale Capital Regulatory News (ACP)

Share Price Information for Armadale Capital (ACP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.775
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.05 (6.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.775
ACP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding and TVR

11 Mar 2022 14:45

RNS Number : 5474E
Armadale Capital PLC
11 March 2022
 

 

Armadale Capital Plc / Index: AIM / Epic: ACP / Sector: Investment Company

 

11 March 2022

 

 

Armadale Capital Plc

('Armadale' or 'the Company')

 

Director/PDMR Shareholding and TVR

 

 

Armadale Capital plc, the AIM quoted investment group focused on natural resource projects in Africa, announces that it has received from Matt Bull, a director, an exercise notice for 7,852,273 warrants to subscribe for ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares"), at an exercise price of 2.2 pence per Ordinary Share, raising £172,750. Accordingly, pursuant to the block admission arrangements announced on 18 June 2020 and 28 June 2021, it has issued 7,852,273 Ordinary Shares to Mr Bull which rank pari passu with the Company's existing Ordinary Shares.

Following the issue of these new Ordinary Shares, the Company's total issued share capital consists of 548,193,824 Ordinary Shares with no shares held in Treasury. This figure may be used as the denominator for the calculations by which shareholders can determine if they are required to notify their interest in, or a change to their interest in, the Company.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain. 

 

 

 

Enquiries:

Armadale Capital Plc

Nick Johansen, Chairman

Tim Jones, Company Secretary

+44 (0) 20 7236 1177

Nomad and broker: finnCap Ltd

Christopher Raggett / Seamus Fricker / Teddy Whiley

+44 (0) 20 7220 0500

 

 

Notes

Armadale's wholly-owned Mahenge Liandu Graphite Project is located in a highly prospective region, with a high-grade JORC compliant indicated and inferred mineral resource estimate announced February 2018 - 59.5Mt at 9.8% TGC. This includes 11.5Mt @ 10.5% Measured 32.Mt Indicted at 9.6% and 15.9Mt at 9.8% TGC, making it one of the largest high-grade resources in Tanzania.

The work to date has demonstrated the Project's potential as a commercially viable deposit, with significant tonnage, high-grade coarse flake and near surface mineralisation (implying a low strip ratio) contained within one contiguous ore body.

The Company's updated Definitive Feasibility Study (June 2020) confirmed Mahenge as a long-life low-cost graphite project with a US$430m NPV and IRR of 91% based on a two-stage expansion strategy comprising:

· Stage One - processing plant and infrastructure at a nominal design basis rate of 0.4-0.5 Mt/pa to produce a nominal 60,000t/pa graphite concentrate in the first three years of production

· Stage Two - a second 0.5 Mt/y plant and associated additional infrastructure doubling throughput to 1 Mt/y from Year 5 of operation

The DFS shows that Armadale can be a significant low-cost supplier to the graphite industry with the potential to generate pre-tax cashflows of US$985m over an initial 15 year mine-life and scope for further improvement as this utilises just 25% of the current resource, which remains open in multiple directions.

Projected timeline to first production is expected to be approximately 10-12 months from the start of construction and the capital cost estimate for Stage 1 is US$39.7m, which includes a contingency of U$S4.1m or 15% of total direct capital cost, with a 1.6 year payback for Stage 1 (after tax) based on an average sales price of US$1,112/t. Stage 2 expansion is expected to be funded from cashflow.

More information can be found on the website www.armadalecapitalplc.com.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them are set out below pursuant to the EU Market Abuse regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Matthew Bull

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Technical Director & Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Armadale Capital plc

b)

 

LEI

 

213800495EK876JETD10

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

0.1p Ordinary Shares

 

 

ISIN: GB00BYMSY631

 

b)

 

Nature of the transaction

 

 Exercise of warrants

 

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

2.2p

7,852,273

d)

 

Aggregated information

- Aggregated volume

- Price

N/A

 

 

e)

 

Date of the transaction

 

11 March 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVSVEILLIF
Date   Source Headline
27th Feb 20242:45 pmRNSMahenge Project Update
19th Dec 202311:15 amRNSBlock listing Interim Review
29th Sep 20237:00 amRNSHalf-year Report
20th Jun 202310:38 amRNSResult of AGM
19th Jun 20237:00 amRNSBlock listing Interim Review
12th May 20237:00 amRNSFinal Results and Notice of AGM
13th Feb 20239:00 amRNSMahenge Project Update
19th Dec 20227:00 amRNSBlock listing Interim Review
29th Sep 20227:00 amRNSHalf-year Report
20th Jun 202210:45 amRNSResult of AGM
17th Jun 20223:30 pmRNSBlock listing Interim Review
23rd May 20227:00 amRNSFinal Results and Notice of AGM
3rd May 20227:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Apr 20227:00 amRNSIssue of Equity Under Block Admission Arrangements
17th Mar 20223:20 pmRNSHolding(s) in Company
11th Mar 20222:45 pmRNSDirector/PDMR Shareholding and TVR
8th Feb 20228:15 amRNSAdvancing Mining Lease and Expanded Footprint
17th Dec 20217:00 amRNSBlock listing Interim Review
15th Dec 20219:30 amRNSManagement Team Enhanced With Key Appointment
1st Dec 20217:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Nov 20217:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Oct 20217:00 amRNSIssue of equity under block admission arrangements
29th Sep 20217:00 amRNSHalf-year Report
3rd Sep 20219:00 amRNSMahenge Mining Licence Granted
31st Aug 20217:00 amRNSNotification of Changes in Major Holdings
6th Aug 20211:25 pmRNSConversion of Loan Notes and Director Shareholding
28th Jun 202112:40 pmRNSBlock Admission & TVR
28th Jun 202112:18 pmRNSAGM Statement
17th Jun 20217:00 amRNSBlock listing Interim Review
28th May 20213:45 pmRNSSubscription and Investment Portfolio Update
28th May 20213:18 pmRNSFinal Results And Notice of AGM
22nd Apr 202110:00 amRNSCompletion of Test Work Program
12th Apr 20219:20 amRNSChange of Adviser
30th Mar 20219:58 amRNSESIA Approval from NEMC of Tanzania
24th Mar 20217:35 amRNSBoard Change
8th Mar 202112:36 pmRNSNotification of Changes in Major Holdings
17th Feb 20214:41 pmRNSSecond Price Monitoring Extn
17th Feb 20214:35 pmRNSPrice Monitoring Extension
10th Feb 202111:00 amRNSArmadale Reports Successful Chinese EPC Test-Work
11th Jan 202111:00 amRNSCSIRO Graphite Test Work Results
17th Dec 20207:00 amRNSBlock listing Interim Review
24th Nov 202012:03 pmRNSTest-Work Commenced with Leading EPC Contractor
20th Nov 20204:41 pmRNSSecond Price Monitoring Extn
20th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Oct 202010:00 amBUSMahenge Graphite Project Update
6th Oct 20204:41 pmRNSSecond Price Monitoring Extn
6th Oct 20204:36 pmRNSPrice Monitoring Extension
29th Sep 20208:46 amBUSHalf-year Report
8th Sep 202012:45 pmBUSEnvironmental and Social Impact Assessment Submitted
13th Aug 20201:15 pmBUSAssessment of Mahenge Natural Flake Graphite for Battery Applications

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.